Euroopan unioni - englanti - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - prostatic neoplasms - endocrine therapy - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5.1).the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5.1).the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5.1).the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astellas pharma malaysia sdn bhd - enzalutamide -

Singapore - englanti - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - enzalutamide - capsule, liquid filled - enzalutamide 40.0 mg

Malta - englanti - Medicines Authority

adalvo limited malta life sciences park, building 1, level 4 sir temi zammit san gwann industrial est, sgn 3000 san gwann, malta - lenalidomide - soft capsule - enzalutamide 40 mg - endocrine therapy

Israel - englanti - Ministry of Health

astellas pharma international b.v., israel - enzalutamide - film coated tablets - enzalutamide 80 mg - enzalutamide - xtandi is indicated for:• the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc).• the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure ofandrogen deprivation therapy in whom chemotherapy is not yet clinically indicated.• the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxeltherapy.• the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy

Kanada - englanti - Health Canada

astellas pharma canada inc - enzalutamide - capsule - 40mg - enzalutamide 40mg - antineoplastic agents

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

astellas pharma ltd - enzalutamide - capsule - 40mg

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - methidathion; xylene - emulsifiable concentrate - methidathion organophosphorus-dithiophospha active 400.0 g/l; xylene solvent other 557.8 g/l - insecticide - apple - dormant treatment | apple - spring and summer treatment | avocado | bean | cereals | citrus | coffee - non-bearing | cot - aphid | argentine stem weevil | armyworm | auger beetle | banana spotting bug | black citrus aphid | black scale | blastobasis spp. | blue oat or pea mite | bluegreen aphid | bronze orange bug | brown olive scale | carmine mite | caterpillar | circular black scale | citrus gall wasp | citrus leafminer | citrus mealy bug | codling moth | common armyworm - mythimna convecta | common slug | couchgrass mite | couchgrass scale | couchtip maggot | cowpea aphid | cutworm | cutworm - agrotis spp. | cymbidium scale | elephant weevil | fig longicorn | fruitspotting bug | grapevine moth | grapevine scale | grasshopper | green coffee scale | grey cluster bug | hemispherical scale | hibiscus mealybug | latania scale | leafhopper | leafminer | leafminer - acrocercops spp. | light brown apple moth | long soft scale | longtailed mealy bug | looper | lucerne aphid | lucerne flea | lucerne leafroller | macadamia felted coccid | macadamia leafminer | macadamia mussel scale | macadamia nutborer | macadamia twig girdler | macadam

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wsd agribusiness pty ltd - alcohol alkoxylate - liquid - alcohol alkoxylate emulsifiers & surfactants active 1000.0 g/l - wetting agent - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - carrier - anti-evaporant | spreading agent | adjuvant | evaporant | herbicide application | insecticide application | wetter

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - calcium chloride dihydrate 0.27 mg/ml; glucose 50 mg/ml; potassium chloride 0.4 mg/ml; sodium chloride 6 mg/ml; sodium lactate 3.22 mg/ml (lactic acid 0.0024ml/ml with sodium hydroxide 1.15mg/ml) - solution for infusion - 5 % - active: calcium chloride dihydrate 0.27 mg/ml glucose 50 mg/ml potassium chloride 0.4 mg/ml sodium chloride 6 mg/ml sodium lactate 3.22 mg/ml (lactic acid 0.0024ml/ml with sodium hydroxide 1.15mg/ml) - compound sodium lactate (hartmann's solution) and 5% dextrose iv infusion solution is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.